{"id":287,"date":"2015-03-10T11:38:55","date_gmt":"2015-03-10T10:38:55","guid":{"rendered":"http:\/\/www.madrimasd.org\/blogs\/msca\/?p=287"},"modified":"2015-03-10T11:38:55","modified_gmt":"2015-03-10T10:38:55","slug":"the-european-commission-will-finance-the-training-of-a-new-generation-of-researchers-in-leishmaniasis","status":"publish","type":"post","link":"https:\/\/www.madrimasd.org\/blogs\/msca\/2015\/03\/10\/287\/","title":{"rendered":"The European Commission Will Finance the Training of a New Generation of Researchers in Leishmaniasis"},"content":{"rendered":"

\"\"<\/a>The\u00a0European Commission<\/strong>\u00a0has granted funding for an\u00a0Innovative Training Network<\/strong>\u00a0within the\u00a0 Marie Sklodowska-Curie – Horizon 2020 programme<\/strong><\/a>, whose goal is to form the next generation of scientists that will contribute to the\u00a0control of leishmaniasis<\/strong>. The\u00a0EUROLEISH-NET<\/strong><\/a>\u00a0project, which will be coordinated by CRESIB\/ISGlobal, is multi- and inter-disciplinary since it includes basic, clinical and translational research to propose integrated solutions in the diagnosis, treatment and prevention of leishmaniasis worldwide.\u00a0Nine public and private European excellence centres<\/strong>\u00a0will host\u00a015 young researchers<\/strong>\u00a0from different backgrounds, including molecular biology, epidemiology, medicine, veterinary and health economy. In addition,\u00a019 institutions or companies<\/strong>\u00a0in and outside Europe will contribute to the formation of the young trainees by offering research visits and know how.<\/p>\n

An important aspect of the Project will be the selection of the students developing the 15 PhD projects that include areas such as drug development, vaccines, diagnostic tools, genetic population studies, vector control and integrated control programmes. The selected candidates will obtain a three-year contract, during which mobility between the 28 institutions in the network will be encouraged in order to enhance synergies between the different participants.<\/p>\n

Leishmaniasis<\/strong><\/a>\u00a0is considered a neglected infectious disease by the\u00a0World Health Organization<\/a> (WHO) and causes an estimated 1.3 million new cases and between 20,000 and 30,000 deaths every year. The disease is caused by a unicellular parasite of the\u00a0Leishmania<\/em>\u00a0genus, is transmitted by the sand fly bite and affects both humans and domestic animals. Although it is globally distributed in South America, Africa, Asia and Europe, it is particularly prevalent among poor communities of developing countries since the major risk factors are poverty, malnutrition, population mobility, environmental changes and climate change. It is the only endemic neglected tropical disease in Europe, where it is mainly a veterinary problem but represents a public health risk.<\/p>\n

Leishmaniasis can be treated and cured. However, global control of the disease requires the development of new strategies and tools that go from the laboratory to the bedside and the community. This is precisely the objective of\u00a0EUROLEISH-NET<\/strong><\/a>.<\/p>\n

Further information and applications via www.euroleish.net<\/a> (deadline for applications 5th<\/sup> April 2015)<\/p>\n","protected":false},"excerpt":{"rendered":"

The\u00a0European Commission\u00a0has granted funding for an\u00a0Innovative Training Network\u00a0within the\u00a0 Marie Sklodowska-Curie – Horizon 2020 programme, whose goal is to form the next generation of scientists that will contribute to the\u00a0control of leishmaniasis. The\u00a0EUROLEISH-NET\u00a0project, which will be coordinated by CRESIB\/ISGlobal, is multi- and inter-disciplinary since it includes basic, clinical and translational research to propose integrated solutions in the diagnosis, treatment and prevention of leishmaniasis worldwide.\u00a0Nine public and private European excellence centres\u00a0will host\u00a015 young researchers\u00a0from different backgrounds, including molecular biology, epidemiology, medicine, veterinary and health economy. In addition,\u00a019 institutions or companies\u00a0in and outside Europe will contribute to the formation of the young\u2026<\/p>\n","protected":false},"author":195,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"ngg_post_thumbnail":0},"categories":[28218,28227],"tags":[],"blocksy_meta":{"styles_descriptor":{"styles":{"desktop":"","tablet":"","mobile":""},"google_fonts":[],"version":4}},"aioseo_notices":[],"_links":{"self":[{"href":"https:\/\/www.madrimasd.org\/blogs\/msca\/wp-json\/wp\/v2\/posts\/287"}],"collection":[{"href":"https:\/\/www.madrimasd.org\/blogs\/msca\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.madrimasd.org\/blogs\/msca\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.madrimasd.org\/blogs\/msca\/wp-json\/wp\/v2\/users\/195"}],"replies":[{"embeddable":true,"href":"https:\/\/www.madrimasd.org\/blogs\/msca\/wp-json\/wp\/v2\/comments?post=287"}],"version-history":[{"count":4,"href":"https:\/\/www.madrimasd.org\/blogs\/msca\/wp-json\/wp\/v2\/posts\/287\/revisions"}],"predecessor-version":[{"id":292,"href":"https:\/\/www.madrimasd.org\/blogs\/msca\/wp-json\/wp\/v2\/posts\/287\/revisions\/292"}],"wp:attachment":[{"href":"https:\/\/www.madrimasd.org\/blogs\/msca\/wp-json\/wp\/v2\/media?parent=287"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.madrimasd.org\/blogs\/msca\/wp-json\/wp\/v2\/categories?post=287"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.madrimasd.org\/blogs\/msca\/wp-json\/wp\/v2\/tags?post=287"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}